Pune, India, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The global Legionella testing market is projected to grow from USD 317.3 million in 2023 to USD 600.1 million by 2030, exhibiting a CAGR of 9.5% during the forecast period. The rising prevalence of pneumonia, Pontiac fever, and Legionnaire's disease is set to augment the Legionella testing market share over the coming years.
Fortune Business Insights™ mentioned this in a report, titled “Legionella Testing Market, 2023-2030.”
Key Industry Development:
- January 2019 - Asahi Kasei Pharma launched the Ribotest Legionella in Japan. The new product would enable the detection of 15 serogroups of Legionella pneumophila, assisting in the diagnosis of Legionnaires’ disease.
Request a Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/legionella-testing-market-102803
Key Takeaways:
- The rising occurrence of the disease is anticipated to drive the growth of the global market.
- The global market is predicted to experience significant growth due to the increasing prevalence of Legionnaire's disease, Pontiac fever, and pneumonia.
- North America market size was USD 115.7 million in 2022.
- Clinical laboratories segment registered the highest revenue and is anticipated to continue this dominance during the forecast period.
List of Key Market Players Profiled in the Report:
“Companies leading the global legionella testing market are Quidel Corporation (U.S.), Abbott (Alere) (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), BD (U.S.), bioMérieux (France), IDEXX Corporation (U.S.), Eurofins Scientific (Luxembourg)”
Report Scope & Segmentation
| Report Coverage | Details |
| Forecast Period | 2023 to 2030 |
| Forecast Period 2023 to 2030 CAGR | 9.5% |
| 2030 Value Projection | USD 600.1 Million |
| Base Year | 2022 |
| Market Size in 2023 | USD 317.3 million |
| Historical Data | 2019 to 2021 |
| No. of Pages | 125 |
| Segments covered | By Type, End-User, and Region |
Browse Complete Report Details: https://www.fortunebusinessinsights.com/legionella-testing-market-102803
Segmentation:
Urine Antigen Testing (UAT) Segment Dominated the Market Owing to Cost-effective Nature
On the basis of type, the market is divided into polymerase chain reaction (PCR), culture media, serology tests, urine antigen testing, and direct antibody fluorescent methods. In 2022, the urine antigen testing segment accounted for the largest market share. This was observed as the testing is cost-effective and is preferred by people living in developing countries. The test is extensively deployed for the detection of Legionella bacteria in urine.
Clinical Laboratories Segment Recorded the Highest Revenue Due to Increasing Occurrence of Disease
By end-user, the market is divided into clinical laboratories, hospitals and clinics, and others representing environmental testing sites. The clinical laboratories segment generated the highest revenue and is set to expand at a considerable rate over the forecast period. This rise is driven by the surging adoption of advanced tests, the growing prevalence of Legionella disease, and increased awareness regarding the disease.
On the basis of geography, the market for Legionella testing has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
By Type
- Culture Media
- Urine Antigen Testing (UAT)
- Polymerase Chain Reaction (PCR)
- Serology
- Direct Fluorescent Antibody (DFA) Test
By End-User
- Hospitals & Clinics
- Clinical Laboratories
- Others
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Quick Buy - Legionella Testing Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102803
Drivers & Restraints:
Strict Restrictions Imposed by Regulatory Bodies for Regular Water Testing to Drive Market Growth
The presence of different types of Legionella in water reservoirs, such as ponds and lakes, swimming pools, and warm water showers in commercial buildings, as well as water supply pipes, is an increasing public health problem. Legionellosis outbreaks result in an increased risk of illness and death among exposed individuals. This has led to an upsurge in the formulation of stringent restrictions pertaining to regular water testing by regulatory bodies. These factors are set to drive Legionella testing market growth over the forthcoming years.
Lack of awareness about the disease in underdeveloped countries may hinder market expansion.
Regional Insights:
North America Dominated the Market Owing to Increasing Occurrence of Legionella Diseases
In 2022, the North America market for Legionella testing was USD 115.7 million. The regional market growth is impelled by the presence of strict water testing regulations and the high diagnosis rate of the disease. Besides, the region is characterized by the presence of world-class health infrastructure.
Europe accounted for the second largest market share. This can be credited to the rising outbreaks of Legionella in the region and the surging adoption of high-cost PCR tests.
Competitive Landscape:
Prominent Players Deploy Acquisition and Merger Strategies to Expand Consumer Base
The Legionella testing sector is dominated by a few major players who are diversifying their offerings with advanced testing techniques such as UAT and PCR. These key players employ collaboration strategies such as mergers, acquisitions, product launches, and joint ventures to broaden their market reach and consumer base.
Speak to Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/legionella-testing-market-102803
FAQ’s
How big is the legionella testing market?
Legionella testing market size was USD 290.4 million in 2022. It is expected to reach USD 600.1 million by 2030.
How fast is the legionella testing market growing?
The legionella testing market will exhibit a CAGR of 9.5% during the forecast period, 2023-2030
Related Reports:
Point of Care Diagnostics Market Growth, Industry Analysis, Demand and Forecast
In-vitro Diagnostics Market Size, Share, Opportunities & Analysis
Veterinary Diagnostics Market Overview, Industry Share and Forecast
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. We aim to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
9th Floor, Icon Tower,
Baner - Mahalunge Road,
Baner, Pune-411045,
Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Attachment
